Pharmaceutical Adverse Event Reports
This dataset provides structured adverse event reports linked to pharmaceutical products and patient outcomes, enabling robust drug safety analysis and regulatory monitoring. It captures detailed patient demographics, drug administration details, event severity, and outcomes, making it ideal for pharmacovigilance, risk assessment, and clinical research.
Sample rows
preview · 8 of 200 rows · all 18 columns| report_idstring | outcomestring | patient_ageinteger | concomitant_drugsstring | report_datedate | patient_idstring | patient_genderstring | drug_idstring | drug_namestring | drug_dosagestring | drug_routestring | adverse_event_termstring | adverse_event_severitystring | adverse_event_onset_datedate | reporter_typestring | reporter_countrystring | medical_historystring | event_descriptionstring |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REP-0001 | recovered | 29 | blank | 2024-03-15 | PAT-1001 | female | DRG-2001 | Amoxicillin | 500mg | oral | nausea | mild | 2024-03-14 | patient | United Kingdom | No significant history | Patient experienced mild nausea shortly after taking the first dose of Amoxicillin. Symptoms resolved without intervention. |
| REP-0002 | recovering | 72 | Metformin, Aspirin | 2024-03-18 | PAT-1002 | male | DRG-2002 | Furosemide | 40mg | intravenous | hypotension | severe | 2024-03-17 | physician | United States | Chronic heart failure, hypertension | Patient developed severe hypotension after intravenous administration of Furosemide. The event required medical intervention and patient is currently recovering. |
| REP-0003 | recovered | 3 | blank | 2024-04-01 | PAT-1003 | female | DRG-2003 | Paracetamol | 120mg | oral | rash | moderate | 2024-03-31 | physician | India | Newborn, no prior history | A moderate cutaneous rash developed in the child following oral administration of Paracetamol. Symptoms improved after discontinuation of the drug. |
| REP-0004 | recovered | 44 | blank | 2024-03-10 | PAT-1004 | male | DRG-2004 | Metformin | 500mg | oral | diarrhea | mild | 2024-03-09 | patient | France | Type 2 diabetes | Patient reported mild diarrhea after beginning Metformin therapy. No intervention was required and symptoms resolved naturally. |
| REP-0005 | not recovered | 81 | Amlodipine | 2024-03-20 | PAT-1005 | female | DRG-2005 | Warfarin | 2mg | oral | bleeding | severe | 2024-03-18 | physician | Germany | Atrial fibrillation, hypertension | Severe gastrointestinal bleeding developed two days after starting Warfarin. Patient remains hospitalized for further management. |
| REP-0006 | recovered | 22 | blank | 2024-02-26 | PAT-1006 | female | DRG-2006 | Ibuprofen | 400mg | oral | headache | mild | 2024-02-26 | patient | Canada | No prior history | Mild headache was noted after taking Ibuprofen for menstrual pain. The symptom resolved spontaneously. |
| REP-0007 | recovered | 7 | blank | 2024-03-29 | PAT-1007 | male | DRG-2007 | Cefalexin | 250mg | oral | vomiting | moderate | 2024-03-28 | physician | Japan | Asthma | Child experienced moderate vomiting after receiving Cefalexin. The event resolved after cessation of the drug. |
| REP-0008 | recovering | 56 | Metformin | 2024-04-03 | PAT-1008 | female | DRG-2008 | Lisinopril | blank | oral | dizziness | moderate | 2024-04-02 | pharmacist | Mexico | Hypertension, diabetes | Patient experienced moderate dizziness after starting Lisinopril. The symptoms are gradually improving with dose adjustment. |
| REP-0009 | not recovered | 67 | Atorvastatin, Clopidogrel | 2024-03-25 | PAT-1009 | male | DRG-2009 | Aspirin | 75mg | oral | gastric ulcer | severe | 2024-03-24 | physician | Italy | Coronary artery disease, hypertension | Severe gastric ulcer developed after prolonged use of Aspirin. Patient has not yet recovered and further treatment is planned. |
| REP-0010 | recovered | 18 | blank | 2024-03-12 | PAT-1010 | female | DRG-2010 | Levothyroxine | 100mcg | oral | palpitations | moderate | 2024-03-11 | patient | France | Hypothyroidism | Patient reported moderate palpitations after increasing Levothyroxine dose. Symptoms resolved after returning to previous dose. |
| REP-0011 | recovering | 84 | Metformin | 2024-03-05 | PAT-1011 | female | DRG-2011 | Insulin glargine | 20 units | subcutaneous | hypoglycemia | severe | 2024-03-05 | physician | United States | Type 2 diabetes, hypertension | Severe hypoglycemia occurred after subcutaneous injection of Insulin glargine. Patient is currently recovering under medical supervision. |
| REP-0012 | recovered | 5 | blank | 2024-02-18 | PAT-1012 | unknown | DRG-2012 | Vitamin K | 2mg | intramuscular | injection site pain | mild | 2024-02-18 | physician | Turkey | No prior history | Child developed mild pain at the injection site after intramuscular administration of Vitamin K. No additional treatment was needed. |
| REP-0013 | recovering | 53 | Amlodipine | 2024-03-02 | PAT-1013 | male | DRG-2013 | Simvastatin | 20mg | oral | muscle pain | moderate | 2024-03-01 | pharmacist | Poland | Hyperlipidemia, hypertension | Moderate muscle pain was reported by the patient after starting Simvastatin. Symptoms are gradually improving after dose adjustment. |
| REP-0014 | recovered | 38 | blank | 2024-04-05 | PAT-1014 | female | DRG-2014 | Sertraline | 50mg | oral | insomnia | mild | 2024-04-04 | patient | Australia | Depression | Patient developed mild insomnia after starting Sertraline. Symptoms resolved after a week without further intervention. |
| REP-0015 | recovering | 63 | Diazepam | 2024-03-21 | PAT-1015 | male | DRG-2015 | Morphine | 10mg | intravenous | respiratory depression | severe | 2024-03-20 | physician | Argentina | Chronic pain, COPD | Patient developed severe respiratory depression after intravenous Morphine. Intensive care admission was required and patient is recovering. |
| REP-0016 | recovering | 60 | Metformin | 2024-02-22 | PAT-1016 | female | DRG-2016 | Amlodipine | blank | oral | edema | moderate | 2024-02-21 | pharmacist | Russia | Hypertension, diabetes | Moderate peripheral edema developed after starting Amlodipine. Symptoms are gradually improving after dose reduction. |
| REP-0017 | recovered | 24 | blank | 2024-03-27 | PAT-1017 | other | DRG-2017 | Diclofenac | 50mg | topical | skin irritation | mild | 2024-03-26 | other | Spain | No prior history | Mild skin irritation was reported after applying topical Diclofenac. The reaction disappeared within 24 hours. |
| REP-0018 | recovered | 47 | blank | 2024-04-08 | PAT-1018 | female | DRG-2018 | Omeprazole | 20mg | oral | constipation | moderate | 2024-04-07 | patient | Brazil | Gastric reflux | Patient experienced moderate constipation after beginning Omeprazole. Symptoms resolved with increased fluid intake. |
| REP-0019 | recovered | 4 | blank | 2024-03-15 | PAT-1019 | male | DRG-2019 | Amoxicillin | 250mg | oral | diarrhea | mild | 2024-03-15 | physician | India | No prior history | Child developed mild diarrhea shortly after starting Amoxicillin. No intervention was required and symptoms resolved. |
| REP-0020 | recovering | 41 | Metformin | 2024-02-28 | PAT-1020 | female | DRG-2020 | Gabapentin | 300mg | oral | drowsiness | moderate | 2024-02-27 | pharmacist | UAE | Type 2 diabetes | Moderate drowsiness was reported after starting Gabapentin. Symptoms are gradually improving with dose reduction. |
What the 200 rows show
from the 200-row sampleRecovered outcome stands out: mean patient_
- 47.5median patient_
age - 4patient genders
- 4reporter types
- 5drug routes
- 5adverse event severities
- 44drug dosages
Median 47.5, from 0 to 91.
- string 15
- integer 1
- date 2
Columns
18 columns in three groups| column | type | description | example |
|---|---|---|---|
| Text 15 columns | |||
report_id | string | Unique identifier for the adverse event reportunique | REP-0001 |
patient_id | string | Unique identifier for the patient involved in the adverse event | PAT-1001 |
patient_gender | string | Gender of the patientmale · female · other · unknown | female |
drug_id | string | Unique identifier for the pharmaceutical product | DRG-2001 |
drug_name | string | Commercial or generic name of the drug | Amoxicillin |
drug_dosage | string | Dosage of the drug administered (e.g., '500mg', '2 tablets')optional | 500mg |
drug_route | string | Route of administration for the drug (e.g., oral, intravenous)6 values · optional | oral |
adverse_event_term | string | Standardized term describing the adverse event (e.g., 'nausea', 'rash') | nausea |
adverse_event_severity | string | Severity of the adverse eventmild · moderate · severe · fatal · unknown | mild |
outcome | string | Patient outcome after the adverse eventrecovered · recovering · not recovered · fatal · unknown | recovered |
reporter_type | string | Type of person reporting the event (e.g., physician, pharmacist, patient)physician · pharmacist · patient · other · optional | patient |
reporter_country | string | Country where the report was submittedoptional | United Kingdom |
concomitant_drugs | string | Comma-separated list of other drugs the patient was taking at the timeoptional | Metformin, Aspirin |
medical_history | string | Relevant medical history of the patientoptional | No significant history |
event_description | string | Detailed narrative description of the adverse eventoptional | Patient experienced mild … |
| Numbers 1 column | |||
patient_age | integer | Age of the patient at the time of the adverse event0 to 120 | 29 |
| Dates and times 2 columns | |||
report_date | date | Date when the adverse event was reported | 2024-03-15 |
adverse_event_onset_date | date | Date when the adverse event beganoptional | 2024-03-14 |
Use it for
A healthcare dashboard
Patient_
age by outcome and a breakdown of concomitant_ drugs. Excel, Power BI or Tableau. Why do the 89 recovered rows have a mean patient_
age of 26.5? A root-cause class exercise
Hand out the rows and one question. The answer is in the data, not in the brief.
- Reports200REP-000129recoveredREP-000272recoveri…REP-00033recovered
A software demo
Believable reports with report_
date, patient_ id and patient_ age to fill a screen in front of a buyer.
blueprint · pharmaceutical-adverse-event-reports
Behind this dataset
Same schema. As many rows as you need.
These 200 rows came out of a blueprint — 18 columns with generation rules behind each one. Open it in Data Factory to retune a column, add your own, wire in foreign keys, and run it at the size you actually need.
- Log event type and severity
- Include drug name and dosage
- Record patient demographics
- Flag serious adverse reactions
- Aggregate by product type
1 credit per row. Preview 20 rows free. Buy rows for the full run.
- Exports
- CSV, JSON, JSONL, Parquet, SQL, Excel, TSV, XML
- Licence
- yours to use, including commercially
- API slug
- pharmaceutical-adverse-event-reports